The pathological features and prognoses of intraductal papillary mucinous neoplasm and mucinous cystic neoplasm after surgical resection: a single institution series

被引:14
作者
Li, Yuqiong [1 ]
Zhu, Zhongfei [2 ]
Peng, Lisi [1 ]
Jin, Zhendong [1 ]
Sun, Liqi [1 ]
Song, Bin [2 ]
机构
[1] Navy Med Univ, Changhai Hosp, Dept Gastroenterol, 168 Changhai Rd, Shanghai 200433, Peoples R China
[2] Navy Med Univ, Changhai Hosp, Dept Hepatobiliary Pancreat Surg, 168 Changhai Rd, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Intraductal papillary mucinous neoplasm (IPMN); Mucinous cystic neoplasm (MCN); Pathological features; Prognosis; Recurrence; INTERNATIONAL CONSENSUS GUIDELINES; RISK-FACTORS; MANAGEMENT; PANCREAS; IPMN; ASSOCIATION; DIAGNOSIS;
D O I
10.1186/s12957-020-02063-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) represent the tumors with malignant transformation potential. The objective of the study was to verify their pathological characteristics, prognoses, and recurrence factors. Methods Two hundred eighteen IPMNs and 27 MCNs resected at a single institution were included. The demographic, preoperative, histopathological, and follow-up data of the patients were recorded and analyzed. Overall survival (OS) and disease-free survival (DFS) were defined as the interval from the date of initial surgery to death or the last follow-up (OS) and to diagnosis of recurrence or death at follow-up (DFS). Results Of the 218 IPMN and 27 MCN patients, 93 (42.7%) and 8 (29.6%) cases were malignant, respectively. IPMNs occurred in older patients compared with MCN patients (median 63 years vs 54 years, P < 0.0001), and MCNs occurred exclusively in females (100%). Of the overall study cohort, the pathological specimens presented peripheral invasion in 37 (15.1%) patients and incisal margin invasion was observed in 46 (18.8%) patients. After a median follow-up of 34 months, 37 (14.9%) patients relapsed. The 5-year OS and DFS rates of IPMNs were 97.5% and 80.6%; and the OS and DFS rates of MCNs were 95.7% and 87.0%, respectively. There were four independent risk factors associated with recurrence: pathological diagnoses with malignancy (odds ratio, OR = 3.65), presence of oncocytic type for IPMN (OR = 1.69), peripheral invasion (OR = 12.87), and incisal margin invasion (OR = 1.99). Conclusions IPMNs and MCNs are indolent tumors with favorable prognoses after surgical resection in terms of their relatively high OS and DFS rate. Patients with malignant pathological-related diagnoses should accept strict tumor surveillance in view of their higher risk of recurrence.
引用
收藏
页数:9
相关论文
共 28 条
  • [1] Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: clinicopathological features and long-term outcomes following a pancreatectomy
    Antonanzas, Javier
    Cienfuegos, Javier A.
    Hurtado-Pardo, Luis
    Panadero, Pablo
    Benito, Alberto
    Pardo, Fernando
    Rotellar, Fernando
    Marti-Cruchaga, Pablo
    Zozaya, Gabriel
    Valenti, Victor
    Luis Hernandez-Lizoain, Jose
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (12) : 768 - 774
  • [2] A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas
    Basturk, Olca
    Hong, Seung-Mo
    Wood, Laura D.
    Adsay, N. Volkan
    Albores-Saavedra, Jorge
    Biankin, Andrew V.
    Brosens, Lodewijk A. A.
    Fukushima, Noriyoshi
    Goggins, Michael
    Hruban, Ralph H.
    Kato, Yo
    Klimstra, David S.
    Kloeppel, Guenter
    Krasinskas, Alyssa
    Longnecker, Daniel S.
    Matthaei, Hanno
    Offerhaus, G. Johan A.
    Shimizu, Michio
    Takaori, Kyoichi
    Terris, Benoit
    Yachida, Shinichi
    Esposito, Irene
    Furukawa, Toru
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (12) : 1730 - 1741
  • [3] Cystic neoplasms of the pancreas
    Brugge, WR
    Lauwers, GY
    Sahani, D
    Fernandez-del Castillo, C
    Warshaw, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (12) : 1218 - 1226
  • [4] Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics
    Crippa, Stefano
    Fernandez-del Castillo, Carlos
    Salvia, Roberto
    Finkelstein, Dianne
    Bassi, Claudio
    Dominguez, Ismael
    Muzikansky, Alona
    Thayer, Sarah P.
    Falconi, Massimo
    Mino-Kenudson, Mari
    Capelli, Paola
    Lauwers, Gregory Y.
    Partelli, Stefano
    Pederzoli, Paolo
    Warshaw, Andrew L.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (02) : 213 - 219
  • [5] European evidence-based guidelines on pancreatic cystic neoplasms
    Del Chiaro, Marco
    Besselink, Marc G.
    Scholten, Lianne
    Bruno, Marco J.
    Cahen, Djuna L.
    Gress, Thomas M.
    van Hooft, Jeanin E.
    Lerch, Markus M.
    Mayerle, Julia
    Hackert, Thilo
    Satoi, Sohei
    Zerbi, Alessandro
    Cunningham, David
    De Angelis, Claudio
    Giovanni, Marc
    de-Madaria, Enrique
    Hegyi, Peter
    Rosendahl, Jonas
    Friess, Helmut
    Manfredi, Riccardo
    Levy, Philippe
    Real, Francisco X.
    Sauvanet, Alain
    Abu Hilal, Mohammed
    Marchegiani, Giovanni
    Esposito, Irene
    Ghaneh, Paula
    Engelbrecht, Marc R. W.
    Fockens, Paul
    van Huijgevoort, Nadine C. M.
    Wolfgang, Christopher
    Bassi, Claudio
    Gubergrits, Natalya B.
    Verbeke, Caroline
    Kloppel, Gunter
    Scarpa, Aldo
    Zamboni, Giuseppe
    Lennon, Anne Marie
    Sund, Malin
    Kartalis, Nikolaos
    Grenacher, Lars
    Falconi, Massimo
    Arnelo, Urban
    Kopchak, Kostantin V.
    Oppong, Kofi
    McKay, Colin
    Hauge, Truls
    Conlon, Kevin
    Adham, Mustapha
    Ceyhan, Guralp O.
    [J]. GUT, 2018, 67 (05) : 789 - 804
  • [6] ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts
    Elta, Grace H.
    Enestvedt, Brintha K.
    Sauer, Bryan G.
    Lennon, Anne Marie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (04) : 464 - 479
  • [7] Fernandezdel CC, 2003, ARCH SURG, V138, P423
  • [8] Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series
    Griffin, James F.
    Page, Andrew J.
    Samaha, Georges J.
    Christopher, Adrienne
    Bhaijee, Feriyl
    Pezhouh, Maryam K.
    Peters, Niek A.
    Hruban, Ralph H.
    He, Jin
    Makary, Martin A.
    Lennon, Anne Marie
    Cameron, John L.
    Wolfgang, Christopher L.
    Weiss, Matthew J.
    [J]. PANCREATOLOGY, 2017, 17 (03) : 490 - 496
  • [9] Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society
    Hirono, Seiko
    Shimizu, Yasuhiro
    Ohtsuka, Takao
    Kin, Toshifumi
    Hara, Kazuo
    Kanno, Atsushi
    Koshita, Shinsuke
    Hanada, Keiji
    Kitano, Masayuki
    Inoue, Hiroyuki
    Itoi, Takao
    Ueki, Toshiharu
    Shimokawa, Toshio
    Hijioka, Susumu
    Yanagisawa, Akio
    Nakamura, Masafumi
    Okazaki, Kazuichi
    Yamaue, Hiroki
    [J]. JOURNAL OF GASTROENTEROLOGY, 2020, 55 (01) : 86 - 99
  • [10] Kloppel G, 1996, HISTOLOGIC TYPING TU